DERM

Journey Medical Corporation

Contracts

Total Value

Stock Metrics

0.0%

Short % Float

20.5d to cover · Moderate squeeze

52.2%

Inst % Float

10 holders · 2026-06-30

Wasatch Advisors L

Top Holder

13.3% of float

34/100

Dilution Score

Medium

55 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

34/100

MEDIUM

Inst: 52.17% · Top: Wasatch Advisors LP

Biotech Analytics

Biotech / Pharma

6.83

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk34

Clinical Trials0

Short Interest10